
Sean C. Barron
Examiner (ID: 726, Phone: (571)270-5111 , Office: P/1653 )
| Most Active Art Unit | 1653 |
| Art Unit(s) | 1653 |
| Total Applications | 723 |
| Issued Applications | 324 |
| Pending Applications | 127 |
| Abandoned Applications | 323 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18334537
[patent_doc_number] => 20230126485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-27
[patent_title] => PANCREATIC STEM CELLS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/145615
[patent_app_country] => US
[patent_app_date] => 2022-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35666
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18145615
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/145615 | PANCREATIC STEM CELLS AND USES THEREOF | Dec 21, 2022 | Abandoned |
Array
(
[id] => 19003853
[patent_doc_number] => 20240067924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/069299
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069299
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069299 | SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS | Dec 20, 2022 | Pending |
Array
(
[id] => 19003853
[patent_doc_number] => 20240067924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-29
[patent_title] => SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 18/069299
[patent_app_country] => US
[patent_app_date] => 2022-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44947
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18069299
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/069299 | SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS | Dec 20, 2022 | Pending |
Array
(
[id] => 19049289
[patent_doc_number] => 20240091258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-21
[patent_title] => ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY
[patent_app_type] => utility
[patent_app_number] => 18/065451
[patent_app_country] => US
[patent_app_date] => 2022-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23156
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18065451
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/065451 | ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY | Dec 12, 2022 | Pending |
Array
(
[id] => 18297980
[patent_doc_number] => 20230107666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Engineered 3D-Printed Artificial Axons
[patent_app_type] => utility
[patent_app_number] => 18/063001
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063001 | Engineered 3D-Printed Artificial Axons | Dec 6, 2022 | Pending |
Array
(
[id] => 18297980
[patent_doc_number] => 20230107666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => Engineered 3D-Printed Artificial Axons
[patent_app_type] => utility
[patent_app_number] => 18/063001
[patent_app_country] => US
[patent_app_date] => 2022-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12483
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063001
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063001 | Engineered 3D-Printed Artificial Axons | Dec 6, 2022 | Pending |
Array
(
[id] => 18469186
[patent_doc_number] => 20230203470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 18/059135
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 133314
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 335
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18059135
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/059135 | COMPOSITIONS OF ADENOSINE DEAMINASE-2 (ADA2), VARIANTS THEREOF AND METHODS OF USING SAME | Nov 27, 2022 | Pending |
Array
(
[id] => 18364893
[patent_doc_number] => 20230146484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => MICROBIAL HOST CELLS FOR PRODUCTION OF STEVIOL GLYCOSIDES
[patent_app_type] => utility
[patent_app_number] => 17/981671
[patent_app_country] => US
[patent_app_date] => 2022-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4105
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17981671
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/981671 | MICROBIAL HOST CELLS FOR PRODUCTION OF STEVIOL GLYCOSIDES | Nov 6, 2022 | Abandoned |
Array
(
[id] => 18211976
[patent_doc_number] => 20230058240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM
[patent_app_type] => utility
[patent_app_number] => 17/975686
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975686 | METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM | Oct 27, 2022 | Pending |
Array
(
[id] => 18211976
[patent_doc_number] => 20230058240
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM
[patent_app_type] => utility
[patent_app_number] => 17/975686
[patent_app_country] => US
[patent_app_date] => 2022-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17975686
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/975686 | METHODS OF GENERATING HORMONE-PRODUCING ORGANOIDS AND REVERSING HYPOGONADISM | Oct 27, 2022 | Pending |
Array
(
[id] => 18612621
[patent_doc_number] => 20230279353
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => METHODS TO ENHANCE DELIVERY AND ENGRAFTMENT OF STEM CELLS INCLUDING THE IDENTIFICATION OF SPECIFIC PROSTAGANDIN E2 RECEPTORS
[patent_app_type] => utility
[patent_app_number] => 17/959242
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17959242
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/959242 | METHODS TO ENHANCE DELIVERY AND ENGRAFTMENT OF STEM CELLS INCLUDING THE IDENTIFICATION OF SPECIFIC PROSTAGANDIN E2 RECEPTORS | Oct 2, 2022 | Abandoned |
Array
(
[id] => 18108047
[patent_doc_number] => 20230000927
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS
[patent_app_type] => utility
[patent_app_number] => 17/941352
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8459
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941352
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941352 | METHODS TO DIFFERENTIATE STEM CELLS INTO HORMONE-PRODUCING CELLS | Sep 8, 2022 | Pending |
Array
(
[id] => 18240051
[patent_doc_number] => 20230072362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => CARDIAC FIBROBLAST DERIVED EXTRACELLULAR MATRIX
[patent_app_type] => utility
[patent_app_number] => 17/929890
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4259
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929890
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929890 | Cardiac fibroblast derived extracellular matrix | Sep 5, 2022 | Issued |
Array
(
[id] => 18109853
[patent_doc_number] => 20230002733
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/895697
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19053
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895697
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895697 | CELLS WITH INCREASED IMMUNO-REGULATORY PROPERTIES AND METHODS FOR THEIR USE AND MANUFACTURE | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18077717
[patent_doc_number] => 20220403329
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => Polymeric Carriers and Methods
[patent_app_type] => utility
[patent_app_number] => 17/889776
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889776
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889776 | Polymeric Carriers and Methods | Aug 16, 2022 | Abandoned |
Array
(
[id] => 18212944
[patent_doc_number] => 20230059208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => SYSTEM AND METHOD FOR MAINTAINING ORGAN VIABILITY
[patent_app_type] => utility
[patent_app_number] => 17/890059
[patent_app_country] => US
[patent_app_date] => 2022-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8194
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17890059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/890059 | SYSTEM AND METHOD FOR MAINTAINING ORGAN VIABILITY | Aug 16, 2022 | Pending |
Array
(
[id] => 20076366
[patent_doc_number] => 12350401
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-08
[patent_title] => Mesenchymal stem cells-hydrogel-biodegradable or mesenchymal stem cells-hydrogel-nondegradable support composition for alleviating or improving epidermolysis bullosa
[patent_app_type] => utility
[patent_app_number] => 17/819220
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 18
[patent_no_of_words] => 4644
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 227
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819220
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819220 | Mesenchymal stem cells-hydrogel-biodegradable or mesenchymal stem cells-hydrogel-nondegradable support composition for alleviating or improving epidermolysis bullosa | Aug 10, 2022 | Issued |
Array
(
[id] => 19372992
[patent_doc_number] => 12064532
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Ovarian-derived hydrogels for biomedical and biotechnology applications
[patent_app_type] => utility
[patent_app_number] => 17/872467
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 10459
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872467
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872467 | Ovarian-derived hydrogels for biomedical and biotechnology applications | Jul 24, 2022 | Issued |
Array
(
[id] => 18168517
[patent_doc_number] => 20230035127
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => CULTURE AND DIFFERENTIATION OF PLURIPOTENT STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/814044
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17535
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814044 | CULTURE AND DIFFERENTIATION OF PLURIPOTENT STEM CELLS | Jul 20, 2022 | Abandoned |
Array
(
[id] => 18075916
[patent_doc_number] => 20220401528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT
[patent_app_type] => utility
[patent_app_number] => 17/860747
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14164
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17860747
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/860747 | DENTAL PRETREATMENT MATERIAL AND DENTAL TISSUE REGENERATION KIT | Jul 7, 2022 | Abandoned |